SIC
PROK icon

Salem Investment Counselors’s ProKidney PROK Stock Holding History

Salem Investment Counselors’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,000
Closed -$33.6K – 1158
2023
Q2 		$33.6K Buy
3,000
+2,537
+548% +$27K ﹤0.01% 593
2023
Q1 		$5.24K Buy
+463
New +$4.93K ﹤0.01% 905

Other funds holding PROK

SCG
Social Capital Group Menlo Park, California $5.16M AUM 66.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Salem Investment Counselors's PROK Position: Q3 2023 in Review

Salem Investment Counselors sold out of ProKidney (PROK) in Q3 2023, closing a stake of 3,000 shares — an estimated $33.6K sold.

Salem Investment Counselors first reported a position in PROK in Q1 2023 and held it in 2 quarters. The position peaked at $33.6K in Q2 2023. 66 funds tracked by Wall St. Rank hold PROK as of Q3 2023.

  • Salem Investment Counselors reported no remaining ProKidney position as of Q3 2023 after selling out during the quarter.
  • Salem Investment Counselors sold 3,000 ProKidney shares in Q3 2023, an estimated $33.6K.
  • Salem Investment Counselors first reported a position in ProKidney in Q1 2023 and held it in 2 quarters.
  • Salem Investment Counselors's ProKidney position peaked at $33.6K in Q2 2023.
  • 66 funds tracked by Wall St. Rank held ProKidney as of Q3 2023.

Based on Salem Investment Counselors's 13F filing for Q3 2023, filed 4 Oct 2023.